PURA VIDA INVESTMENTS, LLC - Q2 2020 holdings

Add to watchlist

$1.04 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 121 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 92.5% .

All

			Value		Shares		↓ Weighting
IWM	Buy	ISHARES TRput	$88,342,000	+176.8%	617,000	+121.3%	8.50%	+124.3%
SPY	Sell	SPDR S&P 500 ETF TRput	$87,574,000	-0.9%	284,000	-17.1%	8.42%	-19.7%
IHI	New	ISHARES TRput	$49,777,000	–	188,000	+100.0%	4.79%	–
XLV	Sell	SELECT SECTOR SPDR TRput	$38,327,000	-42.5%	383,000	-49.1%	3.69%	-53.5%
XBI	Sell	SPDR SER TRput	$37,167,000	-22.6%	332,000	-46.5%	3.58%	-37.3%
NSTG	Buy	NANOSTRING TECHNOLOGIES INC	$31,132,000	+42.1%	1,060,731	+16.4%	2.99%	+15.1%
ATRC	Buy	ATRICURE INC	$30,803,000	+135.7%	685,273	+76.2%	2.96%	+90.9%
INSP	Sell	INSPIRE MED SYS INC	$29,327,000	+33.3%	337,016	-7.7%	2.82%	+8.0%
SYK	New	STRYKER CORPORATIONput	$27,569,000	–	153,000	+100.0%	2.65%	–
ICUI	Buy	ICU MED INC	$24,744,000	-3.3%	134,251	+5.9%	2.38%	-21.7%
ALXN	Sell	ALEXION PHARMACEUTICALS INC	$22,975,000	+23.0%	204,696	-1.6%	2.21%	-0.4%
ALXN	Buy	ALEXION PHARMACEUTICALS INCcall	$22,897,000	+27.5%	204,000	+2.0%	2.20%	+3.3%
STAA	Sell	STAAR SURGICAL CO	$22,018,000	+39.6%	357,780	-26.8%	2.12%	+13.1%
SRPT	Buy	SAREPTA THERAPEUTICS INCput	$21,229,000	+67.7%	132,400	+2.3%	2.04%	+35.9%
INOV	Sell	INOVALON HLDGS INC	$20,169,000	+9.7%	1,047,216	-5.1%	1.94%	-11.2%
BMY	New	BRISTOL-MYERS SQUIBB COcall	$17,993,000	–	306,000	+100.0%	1.73%	–
ESTA	Buy	ESTABLISHMENT LABS HLDGS INC	$17,652,000	+39.1%	944,958	+7.6%	1.70%	+12.7%
UNH	New	UNITEDHEALTH GROUP INCput	$16,812,000	–	57,000	+100.0%	1.62%	–
VRAY	Sell	VIEWRAY INC	$15,328,000	-11.2%	6,842,954	-0.9%	1.47%	-28.1%
VEEV	New	VEEVA SYS INCput	$14,300,000	–	61,000	+100.0%	1.38%	–
XENT	Buy	INTERSECT ENT INC	$13,870,000	+71.7%	1,024,374	+50.2%	1.33%	+39.1%
LHCG	New	LHC GROUP INC	$11,568,000	–	66,359	+100.0%	1.11%	–
OCX	Buy	ONCOCYTE CORP	$11,429,000	-16.4%	5,983,724	+7.3%	1.10%	-32.3%
IVC	Sell	INVACARE CORP	$10,164,000	-14.9%	1,595,609	-0.8%	0.98%	-31.1%
DXCM	Sell	DEXCOM INC	$9,925,000	-0.9%	24,483	-34.2%	0.96%	-19.7%
PROF	Buy	PROFOUND MED CORP	$9,716,000	+83.9%	573,556	+5.8%	0.93%	+49.0%
RCM	Sell	R1 RCM INC	$9,654,000	-1.1%	865,844	-19.4%	0.93%	-19.8%
QTNT	Sell	QUOTIENT LTD	$9,401,000	+41.6%	1,270,434	-24.4%	0.90%	+14.7%
FXH	Sell	FIRST TR EXCHANGE TRADED FDput	$9,200,000	-62.3%	102,000	-69.1%	0.88%	-69.5%
ZBH	Sell	ZIMMER BIOMET HOLDINGS INC	$8,910,000	-20.5%	74,652	-32.7%	0.86%	-35.6%
NVRO	New	NEVRO CORPput	$8,482,000	–	71,000	+100.0%	0.82%	–
ABT	New	ABBOTT LABSput	$8,412,000	–	92,000	+100.0%	0.81%	–
SRPT	Buy	SAREPTA THERAPEUTICS INCcall	$8,177,000	+67.2%	51,000	+2.0%	0.79%	+35.3%
CNMD	New	CONMED CORP	$7,912,000	–	109,900	+100.0%	0.76%	–
SIBN	Sell	SI BONE INC	$7,551,000	+22.3%	473,703	-8.3%	0.73%	-1.0%
KIDS	Buy	ORTHOPEDIATRICS CORP	$7,532,000	+27.9%	172,113	+15.9%	0.72%	+3.6%
LIVN	New	LIVANOVA PLC	$7,290,000	–	151,473	+100.0%	0.70%	–
INOV	Sell	INOVALON HLDGS INCcall	$6,868,000	-13.2%	356,600	-24.9%	0.66%	-29.7%
IMVT	New	IMMUNOVANT INC	$6,594,000	–	270,806	+100.0%	0.63%	–
BSX	Buy	BOSTON SCIENTIFIC CORP	$6,443,000	+58.0%	183,500	+46.8%	0.62%	+28.1%
	Buy	DERMTECH INC	$6,233,000	+79.4%	471,143	+52.5%	0.60%	+45.0%
NVTA	New	INVITAE CORPcall	$6,209,000	–	205,000	+100.0%	0.60%	–
		CYTOKINETICS INCnote 4.000%11/1	$5,963,000	+80.5%	25,000	0.0%	0.57%	+46.4%
MDT	New	MEDTRONIC PLCput	$5,823,000	–	63,500	+100.0%	0.56%	–
OSUR	Buy	ORASURE TECHNOLOGIES INC	$5,648,000	+288.7%	485,600	+259.6%	0.54%	+213.9%
ICUI	Sell	ICU MED INCcall	$5,529,000	-77.4%	30,000	-75.3%	0.53%	-81.7%
MRK	New	MERCK & CO. INC	$5,345,000	–	69,119	+100.0%	0.51%	–
INCY	New	INCYTE CORPcall	$5,302,000	–	51,000	+100.0%	0.51%	–
IMMU	New	IMMUNOMEDICS INC	$5,155,000	–	145,445	+100.0%	0.50%	–
GH	Buy	GUARDANT HEALTH INC	$5,103,000	+34.6%	62,900	+15.5%	0.49%	+9.1%
SILK	New	SILK RD MED INC	$4,981,000	–	118,900	+100.0%	0.48%	–
MNTA	Sell	MOMENTA PHARMACEUTICALS INC	$4,974,000	-25.7%	149,514	-39.3%	0.48%	-39.9%
COO	New	COOPER COS INCput	$4,964,000	–	17,500	+100.0%	0.48%	–
MSON	Buy	MISONIX INC	$4,934,000	+63.7%	363,586	+13.6%	0.48%	+32.7%
LIVN	New	LIVANOVA PLCcall	$4,909,000	–	102,000	+100.0%	0.47%	–
TWST	Sell	TWIST BIOSCIENCE CORP	$4,901,000	-7.2%	108,181	-37.3%	0.47%	-24.9%
ABM	New	ABM INDS INC	$4,763,000	–	131,200	+100.0%	0.46%	–
EW	New	EDWARDS LIFESCIENCES CORPput	$4,630,000	–	67,000	+100.0%	0.44%	–
APYX	Buy	APYX MEDICAL CORPORATION	$4,579,000	+81.6%	825,117	+17.5%	0.44%	+47.2%
AVDL	Buy	AVADEL PHARMACEUTICALS PLCsponsored adr	$4,547,000	+15.3%	562,800	+13.3%	0.44%	-6.6%
OTIC		OTONOMY INC	$4,514,000	+83.8%	1,246,858	0.0%	0.43%	+48.6%
NVTA	New	INVITAE CORP	$4,268,000	–	140,900	+100.0%	0.41%	–
STXS	Sell	STEREOTAXIS INC	$4,024,000	+29.5%	902,275	-12.3%	0.39%	+4.9%
TXG	Sell	10X GENOMICS INC	$3,923,000	+15.2%	43,920	-19.6%	0.38%	-6.7%
KRMD	New	REPRO MED SYS INC	$3,861,000	–	429,916	+100.0%	0.37%	–
CERS	Sell	CERUS CORP	$3,738,000	+18.9%	566,321	-16.3%	0.36%	-3.5%
CPRX	Sell	CATALYST PHARMACEUTICALS INC	$3,648,000	-34.5%	789,603	-45.4%	0.35%	-47.0%
IMMU	New	IMMUNOMEDICS INCcall	$3,615,000	–	102,000	+100.0%	0.35%	–
ABMD	Sell	ABIOMED INCput	$3,623,000	-70.9%	15,000	-82.5%	0.35%	-76.4%
MASI	New	MASIMO CORPput	$3,420,000	–	15,000	+100.0%	0.33%	–
FLDM	New	FLUIDIGM CORP DEL	$3,386,000	–	844,300	+100.0%	0.33%	–
ITMR	Buy	ITAMAR MED LTDsponsored ads	$3,302,000	+83.2%	177,547	+16.1%	0.32%	+48.6%
NVCR	Buy	NOVOCURE LTDcall	$3,285,000	-10.3%	55,400	+1.8%	0.32%	-27.4%
CLDX	New	CELLDEX THERAPEUTICS INC NEW	$3,251,000	–	250,100	+100.0%	0.31%	–
ADPT	Sell	ADAPTIVE BIOTECHNOLOGIES COR	$3,227,000	-40.4%	66,700	-65.8%	0.31%	-51.8%
TRS	New	TRIMAS CORP	$3,185,000	–	133,000	+100.0%	0.31%	–
MRSN	New	MERSANA THERAPEUTICS INC	$2,993,000	–	127,900	+100.0%	0.29%	–
NSTG	New	NANOSTRING TECHNOLOGIES INCcall	$2,994,000	–	102,000	+100.0%	0.29%	–
MYOK	New	MYOKARDIA INC	$2,783,000	–	28,800	+100.0%	0.27%	–
NARI	New	INARI MED INC	$2,767,000	–	57,125	+100.0%	0.27%	–
TGTX	Sell	TG THERAPEUTICS INC	$2,754,000	+56.4%	141,364	-21.0%	0.26%	+26.8%
ARDX	Buy	ARDELYX INC	$2,744,000	+49.1%	396,541	+22.5%	0.26%	+21.1%
GTH	New	GENETRON HLDGS LTDads	$2,617,000	–	216,800	+100.0%	0.25%	–
LYRA	New	LYRA THERAPEUTICS INC	$2,245,000	–	198,011	+100.0%	0.22%	–
NUVA	New	NUVASIVE INCput	$2,087,000	–	37,500	+100.0%	0.20%	–
BCRX	New	BIOCRYST PHARMACEUTICALS INC	$2,080,000	–	436,500	+100.0%	0.20%	–
IRTC	New	IRHYTHM TECHNOLOGIES INCput	$2,028,000	–	17,500	+100.0%	0.20%	–
XLRN	Sell	ACCELERON PHARMA INC	$1,944,000	-71.8%	20,400	-73.4%	0.19%	-77.1%
AMRN	Sell	AMARIN CORP PLCspons adr new	$1,773,000	-26.9%	256,248	-57.7%	0.17%	-40.6%
BMYRT	Buy	BRISTOL-MYERS SQUIBB COright 99/99/9999	$1,653,000	+118.9%	461,622	+132.3%	0.16%	+76.7%
CHAQU	New	CHARDAN HEALTHCR ACQSTN 2 COunit 99/99/9999	$1,617,000	–	153,960	+100.0%	0.16%	–
FLXN	New	FLEXION THERAPEUTICS INC	$1,615,000	–	122,800	+100.0%	0.16%	–
GNLN	Sell	GREENLANE HLDGS INCcl a	$1,611,000	+70.7%	404,679	-26.3%	0.16%	+38.4%
FOLD	New	AMICUS THERAPEUTICS INC	$1,543,000	–	102,300	+100.0%	0.15%	–
CRBP	Buy	CORBUS PHARMACEUTICALS HLDGScall	$1,459,000	+63.9%	173,900	+2.4%	0.14%	+32.1%
XENT	New	INTERSECT ENT INCcall	$1,381,000	–	102,000	+100.0%	0.13%	–
LQDA	New	LIQUIDIA TECHNOLOGIES INC	$1,263,000	–	150,000	+100.0%	0.12%	–
CNST	New	CONSTELLATION PHARMCETICLS I	$1,229,000	–	40,900	+100.0%	0.12%	–
MCRB	New	SERES THERAPEUTICS INCcall	$1,219,000	–	256,000	+100.0%	0.12%	–
QURE	New	UNIQURE NV	$1,154,000	–	25,600	+100.0%	0.11%	–
PSNL	New	PERSONALIS INC	$1,131,000	–	87,211	+100.0%	0.11%	–
BTAI	New	BIOXCEL THERAPEUTICS INC	$1,087,000	–	20,500	+100.0%	0.10%	–
INO	New	INOVIO PHARMACEUTICALS INCcall	$1,078,000	–	40,000	+100.0%	0.10%	–
AGTC	Sell	APPLIED GENETIC TECHNOLOGIES	$1,063,000	+56.3%	191,899	-7.5%	0.10%	+25.9%
RVNC	New	REVANCE THERAPEUTICS INC	$999,000	–	40,900	+100.0%	0.10%	–
LEGN	New	LEGEND BIOTECH CORPsponsored ads	$872,000	–	20,500	+100.0%	0.08%	–
VSTM	New	VERASTEM INC	$862,000	–	501,384	+100.0%	0.08%	–
SVRA	Buy	SAVARA INC	$868,000	+20.1%	348,768	+2.3%	0.08%	-3.5%
ZYNE	New	ZYNERBA PHARMACEUTICALS INCcall	$806,000	–	239,300	+100.0%	0.08%	–
STSA	New	SATSUMA PHARMACEUTICALS INC	$802,000	–	27,872	+100.0%	0.08%	–
	Buy	TRILLIUM THERAPEUTICS INC	$799,000	+104.9%	98,787	+2.4%	0.08%	+67.4%
SRACU		STABLE RD ACQUISITION CORPunit 05/15/2026	$748,000	+0.5%	74,070	0.0%	0.07%	-18.2%
ZYME	New	ZYMEWORKS INC	$739,000	–	20,500	+100.0%	0.07%	–
EOLS	Buy	EVOLUS INCcall	$694,000	+30.7%	131,000	+2.3%	0.07%	+6.3%
	New	GOSSAMER BIO INCnote 5.000% 6/0	$506,000	–	5,000	+100.0%	0.05%	–
EOLS	New	EVOLUS INCput	$434,000	–	81,900	+100.0%	0.04%	–
MLND		MILLENDO THERAPEUTICS INCcall	$225,000	-66.7%	128,000	0.0%	0.02%	-72.5%
SRRA		SIERRA ONCOLOGY INC	$229,000	+23.1%	18,940	0.0%	0.02%	0.0%
	Buy	CATABASIS PHARMACEUTICALS IN	$119,000	+58.7%	18,510	+2.2%	0.01%	+22.2%
FPRX	New	FIVE PRIME THERAPEUTICS INC	$68,000	–	11,100	+100.0%	0.01%	–
SSPKW		SILVER SPIKE ACQUISITION COR*w exp 08/02/202	$25,000	+108.3%	50,000	0.0%	0.00%	+100.0%
ABEO	Exit	ABEONA THERAPEUTICS INC	$0	–	-186,350	-100.0%	-0.05%	–
CBAY	Exit	CYMABAY THERAPEUTICS INCcall	$0	–	-354,000	-100.0%	-0.06%	–
PBYI	Exit	PUMA BIOTECHNOLOGY INC	$0	–	-64,000	-100.0%	-0.06%	–
EOLS	Exit	EVOLUS INC	$0	–	-141,442	-100.0%	-0.07%	–
AXSM	Exit	AXSOME THERAPEUTICS INCcall	$0	–	-10,000	-100.0%	-0.07%	–
CRBP	Exit	CORBUS PHARMACEUTICALS HLDGS	$0	–	-120,000	-100.0%	-0.08%	–
HZNP	Exit	HORIZON THERAPEUTICS PUB L	$0	–	-32,816	-100.0%	-0.12%	–
ZBH	Exit	ZIMMER BIOMET HOLDINGS INCcall	$0	–	-10,000	-100.0%	-0.12%	–
NLTX	Exit	NEOLEUKIN THERAPEUTICS INC	$0	–	-97,397	-100.0%	-0.13%	–
AUPH	Exit	AURINIA PHARMACEUTICALS INC	$0	–	-98,913	-100.0%	-0.17%	–
SELB	Exit	SELECTA BIOSCIENCES INC	$0	–	-624,755	-100.0%	-0.18%	–
NVRO	Exit	NEVRO CORP	$0	–	-20,000	-100.0%	-0.24%	–
AMRN	Exit	AMARIN CORP PLCput	$0	–	-517,600	-100.0%	-0.25%	–
IMMU	Exit	IMMUNOMEDICS INCput	$0	–	-165,600	-100.0%	-0.26%	–
IMVTU	Exit	IMMUNOVANT INCunit 12/18/2024	$0	–	-175,010	-100.0%	-0.34%	–
CSTL	Exit	CASTLE BIOSCIENCES INC	$0	–	-110,899	-100.0%	-0.39%	–
PPD	Exit	PPD INC	$0	–	-205,000	-100.0%	-0.43%	–
GILD	Exit	GILEAD SCIENCES INC	$0	–	-50,000	-100.0%	-0.44%	–
KALA	Exit	KALA PHARMACEUTICALS INCput	$0	–	-436,700	-100.0%	-0.46%	–
GILD	Exit	GILEAD SCIENCES INCcall	$0	–	-55,000	-100.0%	-0.49%	–
QDEL	Exit	QUIDEL CORP	$0	–	-51,999	-100.0%	-0.60%	–
VAR	Exit	VARIAN MED SYS INCput	$0	–	-52,500	-100.0%	-0.64%	–
REGN	Exit	REGENERON PHARMACEUTICALS	$0	–	-11,212	-100.0%	-0.65%	–
MTUM	Exit	ISHARES TRput	$0	–	-60,000	-100.0%	-0.76%	–
TMO	Exit	THERMO FISHER SCIENTIFIC INCput	$0	–	-27,500	-100.0%	-0.93%	–
QQQ	Exit	INVESCO QQQ TRput	$0	–	-67,500	-100.0%	-1.53%	–
ATRC	Exit	ATRICURE INCcall	$0	–	-565,000	-100.0%	-2.25%	–
LLY	Exit	LILLY ELI & COput	$0	–	-150,000	-100.0%	-2.47%	–
MDT	Exit	MEDTRONIC PLCcall	$0	–	-475,000	-100.0%	-5.09%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR/A filed 2021-02-12

Signatures

The EDGAR filing(s) were signed by:

Alyssa Romano — Chief Compliance Officer and Chief Financial Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
ICU MED INC	26	Q2 2023	4.2%
NANOSTRING TECHNOLOGIES INC	26	Q2 2023	3.3%
VIEWRAY INC	25	Q2 2023	3.2%
LIVANOVA PLC	23	Q3 2023	3.8%
ALEXION PHARMACEUTICALS INC	23	Q1 2021	4.3%
INSPIRE MED SYS INC	22	Q3 2023	3.7%
BOSTON SCIENTIFIC CORP	22	Q3 2022	4.8%
INVACARE CORP	22	Q3 2021	2.8%
ESTABLISHMENT LABS HLDGS INC	21	Q3 2023	5.0%
INTERSECT ENT INC	21	Q2 2021	2.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

PURA VIDA INVESTMENTS, LLC Q2 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Stryve Foods Holdings, LLC	April 19, 2023	1,470,649	5.6%
ICAD INC	March 15, 2023	1,277,214	5.0%
ESTABLISHMENT LABS HOLDINGS INC.	February 14, 2023	1,002,767	4.1%
Pulmonx Corp	February 14, 2023	1,216,258	3.2%
Quotient Ltd^{Sold out}	February 14, 2023	0	0.0%
Universe Pharmaceuticals INC^{Sold out}	February 14, 2023	0	0.0%
MedMen Enterprises, Inc.	April 29, 2022	139,755,072	21.4%
INVACARE CORP^{Sold out}	February 14, 2022	0	0.0%
MedAvail Holdings, Inc.	February 14, 2022	714,120	2.2%
TELA Bio, Inc.	February 14, 2022	564,120	3.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings

Type	Filed
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
13F-HR	2024-02-13
SC 13D/A	2023-12-29

View PURA VIDA INVESTMENTS, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

The reported total value is incorrect (1039703000.0 != 1039702000.0)
The reported has been restated
The reported has been amended

Export PURA VIDA INVESTMENTS, LLC's holdings